Publications & Research

Fine-needle aspiration biopsy versus ultrasound-guided fine-needle aspiration biopsy: cost-effectiveness as a frontline diagnostic modality for solitary thyroid nodules

This model estimated that ultrasound-guided fine-needle aspiration biopsy increased the correct classification of thyroid malignancies from 92% with conventional biopsy to 98%, and was a cost-effective strategy at $318 per additional cancer case that was correctly diagnosed.

Click here to view the full study.



  • MITA Smart Initiative

    Promoting patient safety and enhancing the quality of medical imaging technology with MITA Smart Standards. Learn More

  • Fluoro Pharma

    Why I Joined MITA – FluoroPharma Medical, Inc.

    Hear from Thomas Tulip, Ph.D, President, FluoroPharma Medical, Inc. on why his organization joined MITA.

    Learn More